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Although most patients with common mental disorders receive
treatment in primary care,1 there is room for improvement in
the standard of mental healthcare in this setting.2 Multifaceted
interventions that target patients, providers and system changes
have been proposed to improve the quality of treatment for these
conditions in primary care.3,4 The collaborative care model
incorporates multiple interventions and has been extensively
studied in the field of depression treatment5 and to a lesser extent
for anxiety,5,6 yielding positive results. Clinical guidelines are
increasingly focusing on the efficient provision of mental
healthcare, making stepped care an attractive treatment model,
starting with a minimal intervention such as (guided) self-help
in primary care and stepping up to specialised mental healthcare
only when necessary.7,8 Thus far collaborative care studies have
not incorporated stepped care with (guided) self-help as a first
step. Furthermore, most research on collaborative care has
targeted patients with depressive disorders, but anxiety disorders
and stress-related disorders are also frequently seen in primary
care and might also be treated effectively with collaborative care.5,9
Therefore, a study examining the effectiveness of a collaborative
stepped care (CSC) approach for common mental disorders is
needed. Because CSC intervenes at the level of the primary care
practice, we used a pragmatic cluster randomised controlled trial
(RCT) to evaluate response to treatment and remission in patients
with depressive, anxiety or stress-related disorders receiving CSC
or care as usual (CAU).
Method
Design
This Dutch 8-month practice-based study with a 4-month
follow-up phase was designed to evaluate the clinical outcomes
of CSC as compared with CAU in the treatment of common
mental disorders. The CSC treatment algorithm included both
psychological and pharmacological stepwise interventions for the
treatment of patients with anxiety, depressive and stress-related
disorders in both primary care and specialised mental healthcare.
Measurements took place mid-test at 4 months, post-test at
8 months and at 12-month follow-up. The study was approved
by the Medical Ethics Committee of the Twenteborg Hospital
in Almelo (Dutch Trial Register identifier NTR1224, www.
trialregister.nl).
Eligibility criteria for clusters and participants
Clusters
All 30 general practitioners (GPs) established in the region where
the specialised mental healthcare centre is located were contacted
for participation. Inclusion criteria were: (a) the GPs were
working with a psychiatric nurse; and (b) giving informed
consent. After a complete explanation of the study procedures,
informed consent was obtained and the GPs were randomised
to one of the two conditions: CSC or CAU. In addition, two teams
were formed within the specialised mental health centre, each
consisting of four psychiatric nurses, two psychologists and one
psychiatrist. The teams were randomised to one of the two
conditions: CSC or CAU. The randomisation codes were
developed by an independent statistician. The details of the series
were unknown to any of the researchers.
Patients
Inclusion criteria. Included were out-patients aged 18 years or
older with (a) common mental disorders diagnosed by the GP
and (b) who gave written informed consent to participate.
Included were patients with the following DSM-IV10 disorders:
panic disorder, agoraphobia, social phobia, specific phobia,
generalised anxiety disorder, unipolar major and minor depressive
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Background
Thus far collaborative stepped care (CSC) studies have not
incorporated self-help as a first step.
Aims
To evaluate the effectiveness of CSC in the treatment of
common mental disorders.
Method
An 8-month cluster randomised controlled trial comparing
CSC to care as usual (CAU) (Dutch Trial Register identifier
NTR1224). The CSC consisted of a stepped care approach
guided by a psychiatric nurse in primary care with the
addition of antidepressants dependent on the severity of the
disorder, followed by cognitive–behavioural therapy in mental
healthcare.
Results
Twenty general practitioners (GPs) and 8 psychiatric nurses
were randomised to provide CSC or CAU. The GPs recruited
163 patients of whom 85% completed the post-test
measurements. At 4-month mid-test CSC was superior to
CAU: 74.7% (n=68) v. 50.8% (n=31) responders (P=0.003).
At 8-month post-test and 12-month follow-up no significant
differences were found as the patients in the CAU group
improved as well.
Conclusions
Treatment within a CSC model resulted in an earlier
treatment response compared with CAU.
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disorder, dysthymia or one of the stress-related adjustment
disorders.
Exclusion criteria. Patients were excluded when they met the
DSM-IV10 criteria for dependence on alcohol or drugs, dementia,
psychotic disorder or bipolar disorder. Patients with post-
traumatic stress disorder and obsessive–compulsive disorder were
included only when these disorders were comorbid with one of the
disorders in the inclusion criteria. Furthermore, patients were
excluded if they were already undergoing treatment with psycho-
tropic drugs (except for benzodiazepines), cognitive–behavioural
therapy (CBT) or interpersonal therapy for the present episode
of the disorder. In addition, patients were excluded if they were
not sufficiently proficient in the Dutch language to fill in the
measurement scales.
Procedure
Patients who were selected for the study by the GP were visited at
the office of the GP by a trained research psychologist. The
research psychologist administered the Mini International
Neuropsychiatric Interview (MINI),11 which is a structured
psychiatric interview that diagnoses DSM-IV disorders.10 The
purpose of this diagnostic interview was (a) to determine the
primary DSM-IV diagnosis in case of psychiatric comorbidity
and (b) to formally assess the exclusion criteria. In patients with
multiple disorders the primary diagnosis was defined as the
psychiatric disorder from which the patient suffered the most.
This primary diagnosis determined the allocation of the patients
to one of the three different treatment algorithms (one for anxiety
disorders, one for depressive disorders and one for stress-related
disorders; see Fig. 1).
Interventions
Care as usual
The patients treated by the GPs assigned to CAU could obtain any
service normally available in The Netherlands. Thus, CAU could
encompass no treatment, the prescription of antidepressants,
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referral to a psychiatric nurse at the GP’s office, referral to the
specialised mental health centre or to another professional. When
the patients were referred to the specialised mental health centre,
treatment could consist of any type of pharmacotherapy,
psychotherapy or a combination of the two. In The Netherlands,
national guidelines for the treatment of depression and anxiety
disorders are available for GPs and psychiatrists. However,
adherence with these guidelines is not optimal.12
Collaborative stepped care
The patients treated by the GPs assigned to CSC were offered
treatment according to three different treatment algorithms: one
for anxiety disorders, one for depressive disorders and one for
stress-related disorders. The algorithms were described in a
manual, including interventions and treatment decisions (Fig. 1).
Treatment programmes. All patients with stress-related
disorders started with the first step in primary care. For the
anxiety and depression treatment programmes, the level of
severity of the disorder was determined by the number of
symptoms, the severity of symptoms and the degree of functional
impairment as assessed by the psychologist who conducted the
MINI interviews. Patients with mild or moderately severe anxiety
or depressive disorders started treatment with a first-step
treatment in primary care. Patients with a severe disorder were
directly referred to the out-patient department of the specialised
mental health service for the second-step treatment and were
offered CBT and antidepressants. In cases when patients had
depression with psychotic features, were actively suicidal or when
the family of the patient was overly strained due to the psychiatric
disorder, the patients were referred to a (day care) clinic where
they received intensive psychiatric treatment.
First- and second-step interventions. The first-step intervention
was provided in primary care. Patients were offered a 3.5-month
self-help course, with guidance from the psychiatric nurse at the
GP’s office or at home, in five 45-minute sessions. The self-help
course for depression was a widely used course based on the
method of Lewinsohn and colleagues.13 The self-help course
‘Stresspac’ was used for anxiety and stress-related disorders.14
Both courses consist of workbooks with psychoeducation and
cognitive and behavioural exercises and have been shown to be
efficacious in previous studies.14,15
In addition to guided self-help, patients with a moderately
severe anxiety or depressive disorder were offered antidepressant
medication according to disorder-specific algorithms, initially
with a selective serotonin reuptake inhibitor (SSRI). In case of
non-response or low tolerability, in depressive disorder the first-
step SSRI was switched to mirtazapine, venlafaxine or a tricyclic
antidepressant. In panic disorder and social phobia the first-step
SSRI was switched to another SSRI, whereas in generalised anxiety
disorder this second step could also mean a switch to venlafaxine.
Treatment offered in step two consisted of CBT in
combination with antidepressants provided in the out-patient
specialised mental health service.
Monitoring. Remission was evaluated after 4 months (Fig. 1) by
the psychiatric nurse, using the Clinical Global Impression –
Severity scale (CGI-S).16 Patient with scores 53 on the CGI-S
(i.e. mild severity or worse) proceeded to the second-step
treatment: referral to a specialised mental health service. The
evaluation by the psychiatric nurse in CSC was used only to
evaluate treatment progression and to determine whether or not
to ‘step up’ treatment. In contrast, the outcome of CSC and
CAU was evaluated at 4, 8 and 12 months by an independent,
trained rater (see Measurements).
Training. To enhance the adherence of the professionals in the
CSC group to the algorithms, multiple tools were provided at
the cluster level. The GPs received one educational session by a
psychiatrist to clarify the medication algorithm and to advise on
enhancing medication adherence. During the study there was an
opportunity for direct, case-based consultation with the
psychiatrist who was randomised to CSC. This consultation
occurred about once per 2 months. Psychiatric nurses
participated in a 2-day training session in basic CBT strategies.
They had a detailed manual, structured session-by-session, at their
disposal to guide the self-help course. In addition, group
supervision for feedback and adherence to the manual took place
every 2 weeks with an experienced behavioural therapist. The
psychologists who provided the second-step treatment in the
specialised mental health service used CBT session-by-session
protocols commonly used in The Netherlands, which have been
proven efficacious in clinical studies. The psychiatrist used the
same pharmacotherapy algorithm used by the GP.
Measurements
All outcome measures pertained to the level of the patients.
Patients were assessed at baseline, at a 4-month mid-test, an
8-month post-test and at a 12-month follow-up with self-ratings
or with assessor ratings by independent, trained raters, who were
masked to the condition to which the GPs had been allocated
(interrater reliability was not assessed). When patients stopped
treatment prematurely, intensive effort was made to complete all
measurements. In this study we distinguished two types of
individuals who dropped out: (a) those who dropped out from
treatment; and (b) those for whom measurements could not be
completed, i.e. who dropped out of providing data.
Primary outcome measures
Primary outcome measures were the percentage of patients
responding to and remitting after treatment. Response was
defined as a score of 1 (‘very much improved’) or 2 (‘much
improved’) on the assessor-rated Clinical Global Impression of
Improvement Scale (CGI-I) as measured from baseline.16
Remission was defined as a score of 1 (‘normal, not at all ill’) or
2 (‘borderline mentally ill’) on the assessor-rated CGI-S.16 Both
CGI-I and CGI-S were chosen because they are generic outcome
measures that assess severity and change in psychopathology
irrespective of its nature. However, disorder-specific, dimensional
secondary outcome measures were used in addition.
Secondary outcome measures
Secondary outcome measures included disorder-specific
dimensional scales, used to evaluate the severity of symptoms,
patient functioning and satisfaction with treatment. The
assessor-rated Hamilton Rating Scale for Anxiety (HRSA) was
used to measure the presence and severity of anxiety symptoms.17
Depressive symptoms were measured with the self-rated Center
for Epidemiologic Studies Depression Scale (CES-D).18 The self-
rated Fear Questionnaire (FQ)19 was used to assess phobic
avoidance behaviour, the self-rated Symptom Checklist-90-
Revised (SCL-90-R) was used to measure the severity of general
psychoneurotic symptoms,20 and the self-rated Short-Form36Health
Survey (SF-36)21 mental scale was used to measure quality of life.
The patient’s perspective was measured by having patients rate
patient versions of the CGI-I and CGI-S at each point.
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Power considerations and sample size
The aim of the RCT was to detect a clinically relevant 25%
difference in response between CSC and CAU at the 8-month
follow-up. We assumed we would find the following response
percentages: CSC 75% v. CAU 50%, corresponding to Cohen’s
h=0.52. With a two-sided alpha of 0.05, and a beta of 0.20, a
sample of 58 patients per condition was required.22 The estimated
difference of 25% was not based on previous data on collaborative
care effectiveness. At the time the study was designed, no data on
CSC were available in The Netherlands. We based this estimation
on a clinically significant difference that we thought would be
relevant for clinical practice.
We estimated a drop-out rate of 25% from the clusters of eight
participants (on average) per GP and an intraclass correlation of
5%. The intraclass correlation coefficient of 5% was chosen based
on previous experiences with primary care studies. It appeared to
be consistent with an analysis of cluster-based studies in primary
care by Adams and colleagues.23 Thus, a total of 96 patients per
treatment arm were required. During the study, recruitment in
the CAU condition was slower than expected. Also, the drop-out
rate appeared to be lower than expected. The final number of
patients included, 94 in the CSC condition and 64 in the CAU
condition, revealed a power of 0.80 to detect an increase in
response rate from 50 to 75% with a two-sided significance level
of 0.05.
Statistical methods
We used statistical procedures appropriate to the cluster and
longitudinal design. For the primary outcome measures multilevel
logistic regression models were used to correctly estimate the
differences in response and remission between groups (CSC v.
CAU) taking the clustering of patients within general practices
(as a single level) into account by modelling the clustering as
random effects. Statistical significance was evaluated using the
z-statistic. Analysis of the primary outcome measures was
conducted on the intention-to-treat sample using last observation
carried forward, thereby assuming that patients who dropped out
did not respond or remit.
For the secondary measures, a mixed-effects model approach
was applied on the intention-to-treat sample. The model included
measurement (baseline, 4-month mid-test, 8-month post-test and
12-month follow-up), treatment and the measurement treatment
interaction as fixed effects, and GPs (first level) and patients
(second level) as random effects. All tests of treatment effects were
conducted at a two-sided alpha level of 0.05. Data were analysed
using SPSS 13.2 and Stata 11.0 for Windows.
Results
Characteristics and attrition for clusters
and participants
Clusters
Of 30 GPs who were contacted for participation, 8 refused.
Reasons for refusal included an unwillingness to risk allocation
to CAU (n= 5), unwillingness to invest the necessary time
(n= 2) and lack of room for a psychiatric nurse (n=1). Twenty-
two GPs, eight psychiatric nurses, four psychologists and two
psychiatrists working at the community mental health centre were
randomly assigned to either CSC or CAU. Another two GPs
refused to participate after randomisation to CAU, resulting in
ten GPs randomised to each condition (Fig. 2). Clusters ranged
from 1 to 25 included patients (mean number of patients per
cluster 7.9 (s.d. = 7.5)).
Patients
The GPs recruited 163 patients between April 2003 and July 2005,
however 5 individuals did not return the baseline questionnaires
and were therefore excluded from subsequent analysis. The GPs
in the CSC condition had 94 patients v. 64 patients in the CAU
condition. The most common primary diagnosis was a depressive
disorder (n= 73), followed by an anxiety disorder (n= 57) and a
stress-related disorder (n=28).
Drop-out rates
Demographic characteristics and clinical status variables of the
patients at baseline are shown in Tables 1 and 2. Data on primary
outcome measures were obtained from 152/158 (96%) of the
patients at the 4-month mid-test, 139/158 (88%) at the 8-month
post-test and 127/158 (80%) at the 12-month follow-up. Patients
with complete data did not differ significantly from those who
dropped out of providing data with respect to demographic and
clinical variables.
Treatment drop-out from the CSC algorithm as well as CAU was
defined as ceasing contact with the care provider prematurely and
without consultation for 3 months or more before the 8-month
post-test, while psychiatric complaints were not in remission. The
treatment drop-out percentage was 14.9% (n=14) in the CSC group
v. 7.8% (n=5) in the CAU condition (z=1.13, P=0.257). In the
CSC group, significantly more patients dropped out from the
anxiety treatment programme compared with the depression
treatment programme (31.0% (n= 9) v. 8.5% (n=4), z=2.29,
P= 0.022). Patients who left treatment prematurely had a
significantly higher number of mean diagnoses (mean 3.1 v. 2.1,
z=3.21, P= 0.001), a significantly longer duration of their main
diagnosis (mean 6.7 v. 2.8 years, z = 2.07, P=0.041) and were
significantly younger in age (mean 37.9 v. 32.0 years, z= 2.07,
P= 0.039).
Collaborative stepped care treatment
According to the CSC protocol, 88 (94%) of the 94 patients in
the CSC group were allocated to guided self-help, the first-step
treatment. Six patients (6%) in the CSC group had a severe
disorder and were thus directly referred to second-step treatment
(specialised mental healthcare). Of the 88 patients allocated to
the first-step treatment, 9 patients (10%) never started
guided self-help. Of the remaining 79 patients who started guided
self-help, 29 patients (37%) had a mild to moderately severe
disorder and were offered guided self-help; 50 patients (63%)
had a moderately severe disorder and were offered guided self-help
plus antidepressant medication. However, not all patients accepted
medication. Of the 79 patients who started guided self-help, 44
(56%) achieved full remission. The remaining 35 patients (44%)
did not respond to step one. Of these, 20 (25% of the patients
who started guided self-help) started step two and were offered
CBT and pharmacotherapy in the specialised mental healthcare
centre, and 15 (19%) declined further treatment. Another seven
patients who did achieve remission required further specialised
mental healthcare treatment because of additional mental health
issues. Overall, 27 (34%) of the 79 patients who started the
first-step treatment continued their treatment in the specialised
mental healthcare centre.
Care as usual
Of the 64 patients in the care as usual group, 5 terminated
treatment prematurely (defined as having no contact with a care
provider for 3 months or more in the first 8 months of treatment,
while psychiatric symptoms were not yet in remission). In total
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37% (n= 23) of the patients were prescribed antidepressants and
44% (n= 28) of the patients were referred to specialised mental
healthcare.
Primary outcome measures
Collaborative stepped care led to higher response and remission
rates compared with CAU at 4, 8 and 12 months (see online Figs
DS1 and DS2). At the 4-month mid-test, significantly more
patients in the CSC group compared with the CAU group
responded (74.7% (n=68) v. 50.8% (n=31), z=2.99, P=0.003)
and remitted (57.8% (n= 52) v. 31.7% (n= 19), z= 3.09,
P= 0.002). At the 8-month post-test the CAU group improved
and differences were no longer significant (response 80.2%
(n= 73) v. 67.2% (n=41), z=1.80, P= 0.072; remission 58.9%
(n= 53) v. 51.7% (n=31), z=0.87, P= 0.383). At 12-month
follow-up, differences diminished further (response 83.5%
(n= 76) v. 77.0% (n= 47), z= 0.99, P=0.322); remission 73.3%
(n= 66) v. 61.7% (n=37), z= 1.50, P= 0.133), because the
patients in the CAU improved further.
Results for the anxiety and depression programmes are
presented in Table 3. The number of patients allocated to the stress
treatment programme was too small to permit a separate analysis.
In both the anxiety and depression treatment programmes the
response and remission rates of the CSC group were higher than
those of the CAU group at the measurement points. However,
significant differences were found only at the 4-month mid-test.
Secondary outcome measures
Compared with patients in the CAU group, CSC patients had a
significantly larger reduction in anxiety symptoms (HRSA, FQ)
and depressive symptoms (CES-D) after the 4-month mid-test
(Table 2). No significant differences were found on the other
secondary outcome measures when considering the whole
group of patients. In the anxiety treatment programme scores
on the HRSA were significantly more reduced in the CSC
compared with the CAU group (online Fig. DS3). However, for
the depression treatment programme we did not find any
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GPs excluded: n=8; refused to participate: n=8
Patients excluded: n=23; refused to participate: n=7,
Main disorder is none of those mentioned in inclusion criteria: n=5
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Fig. 2 Diagram showing the flow of clusters and patients through the trial.
CAU, care as usual; CBT, cognitive–behavioural therapy; CSC, collaborative stepped care; GP, general practitioner.
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significant differences between the treatment groups on the CES-D
(online Fig. DS4).
Patient perspective
At both the 4-month mid-test and 8-month post-test significantly
more patients in the CSC group rated themselves on the patient
versions of the CGI-I as responders (4-month mid-test: 73.8%
(n=59) v. 43.4% (n= 23), z= 3.45, P= 0.001; 8-month post-test:
75.3% (n=64) v. 59.6% (n= 34), z = 1.96, P= 0.049), however,
at the 12-month follow-up the difference was no longer significant
(82.6% (n= 71) v. 78.0% (n=46), z= 0.69, P=0.492).
Adequacy of pharmacotherapy
During the 8 months of the study, 51 (54.3%) patients in the
CSC group and 42 (65.6%) patients in the CAU group used
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Table 1 Demographic and patient characteristics
Characteristics
Collaborative stepped care group
(n=94)
Care as usual group
(n=64) P
Demographic
Age, years: mean (s.d.) 37.0 (11.8) 39.4 (12.4) 0.23
Female, n (%) 59 (62.8) 39 (60.9) 0.82
Higher education (college or university), n (%) 19 (20.2) 15 (23.4) 0.65
Employed, n (%) 73 (77.7) 43 (67.2) 0.13
Foreign, n (%) 5 (5.3) 6 (9.4) 0.33
Clinical
Number of diagnosis, mean (s.d.) 2.3 (1.2) 2.1 (1.1) 0.29
Duration, year, mean (s.d.) 3.4 (6.3) 3.2 (6.1) 0.83
Psychiatric history, n (%) 34 (36.2) 21 (32.8) 0.66
Severely ill,a n (%) 25 (26.6) 20 (31.3) 0.53
Main diagnosis, n (%)
Any depressive disorder 47 (50.0) 26 (40.6) 0.25
Any anxiety disorder 29 (30.9) 28 (43.8) 0.10
Any stress-related disorder 18 (19.1) 10 (15.6) 0.57
a. Severely ill: at least markedly severe (score 55) on seven-point Clinical Global Impression – Severity scale.
Table 2 Predicted means and standard deviations of patients receiving collaborative stepped care (n = 94) or care as usual
(n = 64) on secondary outcome measures based on multilevel linear regression analysis
Mean (s.d.)
Pre-test Mid-test (4 months) Post-test (8 months) Follow-up (12 months)
Symptom Checklist-90-Revised
Collaborative stepped care 190.27 (46.96) 140.07 (41.76) 133.62 (40.86) 128.27 (41.01)
Care as usual 192.96 (40.58) 151.75 (41.31) 140.07 (35.50) 132.92 (35.42)
Hamilton Rating Scale for Anxiety
Collaborative stepped care 20.44 (8.13) 9.71 (7.57)a 8.72 (7.29) 7.98 (7.06)
Care as usual 20.92 (6.96) 13.59 (7.49) 10.88 (6.25) 8.90 (6.04)
Center of Epidemiologic Studies Depression Scale
Collaborative stepped care 27.64 (10.89) 13.75 (9.97)a 12.82 (9.91) 11.22 (9.81)
Care as usual 26.67 (9.32) 17.57 (9.94) 14.46 (8.54) 12.47 (8.39)
Fear Questionnaire
Collaborative stepped care 24.29 (16.88) 16.96 (14.12)a 16.79 (13.91) 12.62 (13.86)b
Care as usual 22.45 (14.60) 21.90 (14.03) 18.61 (12.02) 16.04 (11.90)
Short-Form 36 Health Survey
Collaborative stepped care 40.48 (20.68) 63.65 (18.64) 64.95 (18.03) 69.99 (17.73)
Care as usual 40.43 (17.86) 60.01 (18.42) 70.10 (15.62) 68.89 (15.34)
a. Significant difference: collaborative stepped care v. care as usual P<0.05.
b. Trend for difference: collaborative stepped care v. care as usual P<0.1.
Table 3 Response and remission rates per treatment programme: intention-to-treat sample
Anxiety treatment programme, n (%) Depression treatment programme, n (%)
Collaborative stepped care group Care as usual group Collaborative stepped care group Care as usual group
Assessment
Response
(n=28)
Remission
(n=28)
Response
(n=27)
Remission
(n=27)
Response
(n=46)
Remission
(n=45)
Response
(n=25)
Remission
(n=24)
Mid-test (4 months) 21 (75.0)a 16 (57.1)a 12 (44.4) 7 (25.9) 34 (73.9) 23 (51.1)a 14 (56.0) 6 (25.0)
Post-test (8 months) 23 (82.1) 16 (57.1) 18 (66.7) 13 (48.1) 38 (82.6) 26 (57.8) 16 (64.0) 10 (41.7)
Follow-up (1 year) 24 (85.7) 22 (78.6) 22 (81.5) 18 (66.7) 37 (80.4) 30 (66.7) 17 (68.0) 11 (45.8)
a. Pearson w2 is significant at P50.05.
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psychopharmaceuticals (z=71.36, P=0.173). At baseline, 22
(23.4%) patients in the CSC group and 17 (27.4%) patients in
the CAU group were prescribed benzodiazepines (z=70.57,
P= 0.571). Throughout the study, benzodiazepines were less often
prescribed in the CSC group compared with the CAU group
(32.3% (n=30) v. 51.6% (n=33), z= –2.41, P=0.016). Also, they
were prescribed for a shorter duration in the CSC group compared
with the CAU group, resulting in very low benzodiazepine
prescription rates at the 8-month post-test and the 12-month
follow-up (6.4% (n=6) v. 29.0% (n=18), z=73.54, P50.001).
Prescription of antidepressants was higher in the CSC group
compared with the CAU group (45.7% (n= 43) v. 36.5%
(n= 23), z= 1.06, P=0.287). The GPs in the CSC group mainly
prescribed SSRIs (81% (n=38) of the prescriptions), in contrast
to the CAU group in which, next to SSRIs (42% (n=10) of
prescriptions), 46% (n=11) of the prescriptions consisted of an
serotonin noradrenaline reuptake inhibitor or mirtazapine.
Absenteeism from work
Almost half of the patients reported no sickness absence during
the study. About 10% of the patients reported sickness absence
that lasted the entire observation period of 34 weeks, and the
remainder (40%) reported sickness absence that lasted between
0 and 34 weeks. Patients in the CSC condition reported less
sickness absence (25%) than patients in the CAU condition
(33%), z=71.68, P= 0.094).
Use of services
No significant differences between the CSC and CAU condition
were found, considering the total number of visits to the primary
care physician and mental health workers (7.8 v. 7.1, P=0.490).
The intensiveness of care performed by psychiatric nurses in
primary care increased significantly in the CSC condition
compared with the CAU condition (3.5 v. 2.0 visits, P50.009).
Discussion
Main findings
Our results suggest that at the 8-month post-test and the 12-
month follow-up CSC and CAU do not differ significantly from
each other. However, significant differences in response and
remission rates between CSC and CAU after 4 months suggest that
the patients treated with CSC experience a faster response and
remission of symptoms. In this study, patients in the CAU group
also improved considerably, which may reflect a high degree of
quality of usual care in our study compared with other
collaborative care studies.5 Despite the high quality of care, this
study shows that the organisation of care in The Netherlands
may profit from the rapid provision of low-intensity treatments
in primary care and improved collaboration between healthcare
providers as established with CSC. Assessment of the patients’
perspectives and acceptability showed they generally favoured
the CSC model above CAU.
Strengths and limitations
A strength of this study is that it evaluates a comprehensive
stepped-care approach, starting with guided self-help and
incorporating primary care and specialised mental healthcare for
three highly prevalent classes of mental disorders. The cluster
design of the study ensured a naturalistic treatment setting for
both CSC and CAU. A limitation of this trial is the smaller
number of patients included in the CAU group compared with
the CSC group. It was difficult to motivate busy GPs who were
randomised to the CAU group to include patients as controls, a
problem which has been encountered before in primary care
studies.24,25 Furthermore, cluster randomisation followed by the
selection of patients by GPs carries a risk of selection bias.
However, in our study no significant differences at baseline on
clinical and demographic variables were found, which may
indicate that GPs selected similar patients in each condition.
Comparison with the literature
The present study is one of the few CSC studies performed to date
that includes multiple psychiatric disorders. Compared with most
studies describing collaborative care for depression or anxiety, the
results from our study are somewhat less promising as we only
found a significant difference between CSC and CAU after 4
months.5 This is probably as a result of the relatively high response
rate in both treatment groups (84% for CSC and 77% for CAU
after 12 months). The high response rate in CAU at follow-up
may be a consequence of the natural course of the illnesses,
although it is more likely caused by a high level of treatment
adequacy by GPs in our care as usual group.2 Indeed, a large
number (44%) of the patients in the CAU group were referred
to specialised mental healthcare. A previous study has already
demonstrated a similar effectiveness of collaborative care
compared with direct referral to specialised mental healthcare.25
Furthermore, Patel and colleagues26 reported significant effects
of collaborative care for common mental disorders in public
primary care practices and no effect in private primary care
practices, which suggests a diminished effectiveness of
collaborative care in systems with a high degree of quality
of care.
Anxiety disorder treatment programme
Disorder-specific secondary outcome measures suggested that
treatment effects were most pronounced in the anxiety treatment
programme. This is remarkable because more patients in the
anxiety treatment programme discontinued treatment compared
with patients in the depression treatment programme. The reason
for this difference in drop-out rate is unclear. The benefit in the
anxiety treatment programme may be explained by the fact that
treatment of anxiety disorders in The Netherlands is less adequate
than that for depressive disorders.5
Use of benzodiazepines
It is noteworthy that after only a low-intensity intervention
consisting of a single educational session and a written
prescription manual, the adequacy of benzodiazepine prescribing
considerably improved in CSC. Besides the education of GPs, this
effect may have resulted from the use of self-help as an alternative
to benzodiazepines.
Implications
This study is the first CSC study including psychotherapeutic
interventions and pharmacotherapy in primary and secondary
care for common mental disorders. In this study, CSC improved
outcomes and quality of care in patients with anxiety, depressive
and stress-related disorders, predominantly in the short term.
The model justifies replication in larger samples with special
attention to its cost-effectiveness.
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Fig. DS1 Responder rates for collaborative stepped care v. care as usual (intent-to-treat 
sample). 
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Fig. DS2 Remission rates for collaborative stepped care v. care as usual (intent-to-treat 
sample). 
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Fig. DS3  Outcomes for collaborative stepped care v. care as usual in the treatment 
programmes for (a) anxiety (measured with the Hamilton Rating Scale for Anxiety) and (b) 
depression (measured with the Center of Epidemiologic Studies Depression Scale). 
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